These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1468 related items for PubMed ID: 10880025

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 6. [Vesicular stomatitis virus G-protein retrovector mediated a herpes simplex virus thymidine kinase gene transduction and expression in the human retinal pigment epithelial cells].
    Wang F, Wang HW, Lu DR, Xue JL, Zhang X.
    Zhonghua Yan Ke Za Zhi; 2003 Apr; 39(4):201-5. PubMed ID: 12882696
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A, Ben-Kasus T, Mahajna JA, Danon A, Rimon G, Agbaria R.
    Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
    [Abstract] [Full Text] [Related]

  • 10. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R, Schniewind B, Boehle AS, Haye S, Boenicke L, Dohrmann P, Kalthoff H.
    Anticancer Res; 2004 Dec; 24(2B):827-31. PubMed ID: 15161034
    [Abstract] [Full Text] [Related]

  • 11. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J.
    Cancer Res; 1999 May 15; 59(10):2384-94. PubMed ID: 10344748
    [Abstract] [Full Text] [Related]

  • 12. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S, Oligino T, Krisky D, Marconi P, Fink D, Cohen J, Glorioso JC.
    Cancer Res; 1998 Dec 15; 58(24):5731-7. PubMed ID: 9865731
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K, Loimas S, Wahlfors J, Alhava E, Jänne J.
    J Gene Med; 2000 Dec 15; 2(5):361-7. PubMed ID: 11045430
    [Abstract] [Full Text] [Related]

  • 14. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE, Yu HM, Liu RS, Lin M, Gelovani JG, Hwang JJ, Wei HJ, Deng WP.
    J Nucl Med; 2006 Jul 15; 47(7):1161-71. PubMed ID: 16818951
    [Abstract] [Full Text] [Related]

  • 15. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S, Steffens S, Fischer U, Tlolko A, Rainov NG, Kramm CM.
    Cancer Gene Ther; 2002 Feb 15; 9(2):178-88. PubMed ID: 11857036
    [Abstract] [Full Text] [Related]

  • 16. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H, Fischer YH, Giroglou T, Rueger MA, Winkeler A, Li H, Himmelreich U, Stenzel W, Jacobs AH, von Laer D.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [Abstract] [Full Text] [Related]

  • 17. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Nov 15; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y, Gilbert JD, Kim JH, Freytag SO.
    Clin Cancer Res; 1999 Dec 15; 5(12):4224-32. PubMed ID: 10632364
    [Abstract] [Full Text] [Related]

  • 19. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells.
    Balzarini J, Degrève B, Andrei G, Neyts J, Sandvold M, Myhren F, de Clercq E.
    Gene Ther; 1998 Mar 15; 5(3):419-26. PubMed ID: 9614564
    [Abstract] [Full Text] [Related]

  • 20. Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase.
    Kunishige I, Samejima Y, Shiki Y, Moriyama A, Meruelo D, Saji F, Murata Y.
    Gynecol Oncol; 1999 Jan 15; 72(1):16-25. PubMed ID: 9889024
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 74.